PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Copaiba oil presented bactericidal and/or bacteriostatic effects in in vitro analyses; one study found Copaifera officinalis similar to chlorhexidine [PMID:29193389]
Two studies reported beneficial wound healing effects, including early reduction in wound area [PMID:35243105]
Oral administration (200-400 mg/kg) provided dose-dependent protection against ethanol and restraint stress-induced damage and prevented indomethacin-induced ulceration [PMID:9720615]
Oral or rectal pretreatment (200-400 mg/kg) significantly reduced gross damage scores and colonic myeloperoxidase activity [PMID:15182904]
Potential benefits are unproven; human data are sparse, consisting of one case series and one small RCT for a different inflammatory condition [PMID:30881236]
Safety & adverse effects
Pregnancy & lactation
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 36903915 (2023) — Toxicological Effects of Copaiba Oil (Copaifera spp.) and Its Active Components. · Plants (Basel, Switzerland)
- 2.PMID: 29193389 (2018) — Antimicrobial activity of copaiba oil (Copaifera ssp.) on oral pathogens: Systematic review. · Phytotherapy research : PTR
- 3.PMID: 29783680 (2018) — Copaifera of the Neotropics: A Review of the Phytochemistry and Pharmacology. · International journal of molecular sciences
- 4.PMID: 37719866 (2023) — Evaluation of the biological activities of Copaiba (Copaifera spp): a comprehensive review based on scientometric analysis. · Frontiers in pharmacology
- 5.PMID: 28977501 (2017) — Development of a Gas Chromatography Method for the Analysis of Copaiba Oil.